The global capsule endoscopy market size reached US$ 448.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 728.2 Million by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2022-2028.

Capsule endoscopy refers to a diagnostic procedure used for obtaining images of the esophagus, stomach and small intestines. It involves the use of a small capsule-encased camera, which is swallowed and passed through the gastrointestinal (GI) tract. The procedure is minimally invasive (MI), painless and does not require the administration of anesthesia. It enables the physician to take thousands of images of the internal organs which are not accessible through the traditionally used imaging solutions. As a result, capsule endoscopy is widely used in the diagnosis and treatment of gastrointestinal cancer, chronic abdominal pain, Crohn’s disease, celiac disease, excessive bleeding and ulcers.

Capsule Endoscopy Market Trends:
The increasing prevalence of gastrointestinal disorders and colorectal cancer across the globe is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the availability of painless and MI visualization procedures for the treatment of such ailments is providing a thrust to the market growth. Esophageal, small bowel and colon capsule endoscopes are extensively used across hospitals and other healthcare centers for timely diagnosis and improved patient care. In line with this, the rising geriatric population, which is more susceptible to ailments, such as inflammatory bowel disease, Obscure Gastrointestinal Bleeding (OGIB) and appendicitis, is also contributing to the growth of the market. Additionally, various technological advancements, such as the development of capsules with longer battery life and Wi-fi compatibility, are acting as other growth-inducing factors. Product manufacturers are also developing user-friendly and high-resolution cameras with a 360-degree panoramic view. Other factors, including rising expenditure capacities of the consumers, along with extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global capsule endoscopy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, accessory and application.

Breakup by Product:

Small Bowel

Breakup by Accessory:

Wireless Capsule
Workstation and Recorder

Breakup by Application:

Small Intestine Tumors

Breakup by Region:

North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CapsoVision Inc., Check Cap Ltd, Fujifilm Holdings Corporation, IntroMedic Co. Ltd, Jinshan Science & Technology (Group) Co. Ltd., Medtronic plc, Olympus Corporation, RF Co. Ltd. and Shangxian Minimal Invasive Inc.

Key questions answered in this report:
How has the global capsule endoscopy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global capsule endoscopy market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the accessory?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global capsule endoscopy market and who are the key players?
What is the degree of competition in the industry?